Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults

NCT04187560 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

LB Pharmaceuticals Inc.